Printer Friendly

AMERICAN BIODYNAMICS, INC. ANNOUNCES SETTLEMENT

 AMERICAN BIODYNAMICS, INC. ANNOUNCES SETTLEMENT
 HOUSTON, Jan. 8 /PRNewswire/ -- American Biodynamics, Inc.,


(NASDAQ: BDYNF) today announced the settlement of all outstanding litigation matters with Weldon S. Guest, a former director of the company. Under the terms of the final settlement, Guest relinquished fully his claims regarding royalties purportedly due him under a royalty agreement and monies under a terminated employment agreement.
 Concurrently, Guest and American Biodynamics entered into a non- compete agreement prohibiting him from competing with the company in the allograft tissue market for the length of the payment period. Further, he will not participate in the marketing or selling of any autotransfusion device for a period of one year. Additionally, Guest agreed to a stand still agreement prohibiting interference with the operations of the company or its management for the payment period. In return for these agreements, the company will pay Guest $352,500 over a three year period. If the company elects, it can pay $399,394 over a four year period. A total of $45,000 was paid against the amount owed at closing.
 John V. Hargiss, president, stated that, "The board and management of American Biodynamics are satisfied with this settlement, as it allows management to now devote full attention to the company's strategic goals and objectives. This settlement should not have a material adverse impact on the company, as management is confident that expected improvements in market share, sales and profits will offset this obligation."
 American Biodynamics offers surgical products which reduce or eliminate the risk of complications from donor tissue grafts and blood. The company is chartered in British Columbia, Canada, and has its executive offices in Houston.
 -0-
 /CONTACT: John V. Hargiss or Marti Bruce of American Biodynamics, 713-862-6622/
 (BDYNF) CO: American Biodynamics Inc. ST: Texas IN: HEA SU: SM -- NY097 -- 7819 01/08/92 13:06 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 8, 1992
Words:306
Previous Article:CARNIVAL SETS RESERVATIONS RECORDS
Next Article:TWA EXTENDS LEASES ON 35 DC-9 AIRCRAFT
Topics:


Related Articles
AMERICAN BIODYNAMICS ANNOUNCES ANNUAL MEETING RESULTS
AMERICAN BIODYNAMICS ANNOUNCES FY 1991 RESULTS
AMERICAN BIODYNAMICS, INC. ANNOUNCES PRIVATE PLACEMENT FINANCING
AMERICAN BIODYNAMICS ANNOUNCES FIRST QUARTER RESULTS
AMERICAN BIODYNAMICS SHAREHOLDERS APPROVE MOVE OF COMPANY AND NAME CHANGE
Biodynamics International, Inc. Announces Office Move
Biodynamics International, Inc. Announces Delisting of Company's Securities From the Nasdaq(SM) Stock Market
Biodynamics Enters Into A Worldwide License And Distribution Agreement With Mentor For Tutoplast(R) Processed Fascia Lata In Urology
Biodynamics Implements Name Change To Tutogen Medical, Inc.
Tutogen Reports Continuation Of Improving Results

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters